The European Federation of Pharmaceutical Industries and Associations (EFPIA) has issued a “Code on Disclosure of Transfers of Value from Pharmaceutical Companies to Healthcare Professionals and Healthcare Organizations” (Disclosure Code). According to EFPIA Director General Richard Bergström, “This is an important step for our industry, as we demonstrate our commitment to transparency and secure the trust of the patients our industry serves.”

Adopted by the trade organization in late June 2013, the Disclosure Code will require member companies to disclose on their Web sites or a central platform (i) “The names of healthcare professionals and associations that have received payments or other transfers of value,” and (ii) “The amounts or value transferred, and the type of relationship, such as consultancy fees, payment for travel or congress fees.” The data will not become public until 2016 and will include information from 2015 forward only. Sanctions for code transgressions “should be proportionate to the nature of the infringement, have a deterrent effect and take account of repeated offences of a similar nature or patterns of different offences. A combination of publication and fines will generally be considered to be the most effective sanction.” See EFPIA Press Release, July 2, 2013.